The following list of Current Clinical IBC Trials Open for New Patient Enrollment was shared by MD Anderson in their Illuminating Hope Newsletter, Issue 31, April 2023. Neoadjuvant (newly diagnosed before surgery): None currently – study is on hold for modifications....
Currently Enrolling Clinical Trials for IBC (designed for IBC patients or building on IBC research) Neoadjuvant trials: A Randomized Phase II Study of Neoadjuvant Carboplatin/Paclitaxel (CT) Versus Panitumumab/Carboplatin/Paclitaxel (PaCT) Followed by...
Alternative Drug Names: Ruxolitinib (Jakafi brand in the US) was previously also known as INCB018242. Paclitaxel is often shortened as “taxol”. “AC” is short for adriamycin and cyclophosphamide. Doxorubicin is another name for Adriamycin. Cyclophosphamide may also be...
Alternative Drug Names: Eribulin is also known as Halaven (US brand name) and previously known as B1939 mesylate. “AC” is short for adriamycin and cyclophosphamide. Doxorubicin is another name for Adriamycin. Cyclophosphamide may also be called Cytoxan (brand name)....
Alternative Drug Names: Atezolizumab is also known as Tecentriq. Cobimetinib is also known as Cotellic. Eribulin is also called Halavan. Purpose of Trial: This is a trial of a novel combination for chemotherapy-resistant metastatic IBC. The purpose is to determine the...
Alternative Drug Names: Keytruda is the brand name for Pembrolizumab. It used to be called MK-3475 Purpose of Trial: This trial is testing the concept that activating the immune system in patients who had residual alive cancer at mastectomy will reduce recurrence more...
